
Overview
Joining Ironwood Cancer & Research Centers in 2004, Dr. Shtivelband received his medical degree and PhD in Experimental Hematology in Russia. After Internal Medicine Residency, Dr. Shtivelband received fellowship training in Hematology and Medical Oncology at MD Anderson Cancer Center in Houston, where he stayed for an additional year to participate in experimental research. Treating patients with all kinds of malignancies and benign hematological problems, Dr. Shtivelband has particular interest in developing research programs to bring the newest advances in the field of Oncology and Hematology to our community. Dr. Shtivelband also heads the Ironwood Cancer & Research Center's research program. He is Board Certified in Internal Medicine, Hematology and Medical Oncology.
Dr. Shtivelband is rated as an Experienced provider by MediFind in the treatment of Folate Deficiency. His top areas of expertise are Hemochromatosis, Non-Small Cell Lung Cancer (NSCLC), Plasmacytoma, and Lung Cancer.
His clinical research consists of co-authoring 13 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- OTHER MEDICARE
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
695 S Dobson Rd, Chandler, AZ 85224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Honorhealth Ambulatory
John Bibb is an Oncologist and a Hematologist Oncology provider in Phoenix, Arizona. Dr. Bibb is rated as a Distinguished provider by MediFind in the treatment of Folate Deficiency. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Hemochromatosis, and Pleuropulmonary Blastoma. Dr. Bibb is currently accepting new patients.
Arizona Center For Hematology And Oncology
Robin Obenchain is a Hematologist in Chandler, Arizona. Dr. Obenchain is rated as a Distinguished provider by MediFind in the treatment of Folate Deficiency. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Obenchain is currently accepting new patients.
Ironwood Physicians, PC
Dr. DeRoock joined Ironwood Cancer & Research Centers in 2009 after completing residency in Internal Medicine followed by fellowship in Hematology and Oncology at the University of California at Davis. He is a first-generation Panamanian-American fluent in both English and Spanish. He previously earned his medical degree at the University of Arizona. Dr. DeRoock is board certified in Internal Medicine, Hematology and Medical Oncology. He has been active in developing clinical trials for pancreatic cancer and lymphoma, and has presented his research findings at the American Society of Hematology Annual Meeting as well as the Annual Pan-Pacific Lymphoma Conference. He specializes in all adult cancers and hematologic disorders.Supportive Cancer Care You Can TrustYou can find that team at Ironwood Cancer & Research Centers. With community-based centers strategically located throughout the Metro Phoenix area, Ironwood offers advanced therapies and a multi-disciplinary approach usually associated with large academic centers – but with a personalized touch recognizing the individual needs of the patient.Studies have shown the importance of a multi-disciplinary approach in effectively treating cancer. We spare you time and worry simply by having all the doctors, therapists, and resources you need in one convenient location, eliminating the delays and miscommunication. These collaborative efforts ensure the highest standards of care. Because Ironwood is actively involved in cutting-edge research, you can also benefit from promising new treatments through participation in clinical trials. Dr. Deroock is rated as a Distinguished provider by MediFind in the treatment of Folate Deficiency. His top areas of expertise are Pulmonary Embolism, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Shtivelband isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AstrocytomaDr. Shtivelband isDistinguished. Learn about Astrocytoma.
- Breast CancerDr. Shtivelband isDistinguished. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Shtivelband isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- EGFR Positive Lung CancerDr. Shtivelband isDistinguished. Learn about EGFR Positive Lung Cancer.
- HemochromatosisDr. Shtivelband isDistinguished. Learn about Hemochromatosis.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shtivelband isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Shtivelband isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Shtivelband isAdvanced. Learn about Anemia.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Shtivelband isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Autoimmune Hemolytic AnemiaDr. Shtivelband isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shtivelband isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Monoblastic Leukemia (AmoL)Dr. Shtivelband isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Shtivelband isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Shtivelband isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myelomonocytic LeukemiaDr. Shtivelband isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Shtivelband isExperienced. Learn about Adult Immune Thrombocytopenia.

